Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.51 |
| ▸ | TSHR | P16473 | 1/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 9/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 7/20 | 0.40 |
| ▸ | FGFR1 | P11362 | 2/20 | 0.39 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.33 |
| ▸ | AHCY | P23526 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10817760 | 0.95 | CYP1A2 (0.48) | CYP1A2TSHRCYP3A4CYP2D6FGFR1 | |
| SCHEMBL9584012 | 0.88 | CYP1A2 (0.52) | CYP1A2TSHRCYP3A4CYP2D6ALDH1A1 | |
| SCHEMBL10814397 | 0.86 | CYP2C19 (0.43) | CYP1A2TSHRCYP3A4CYP2D6FGFR1 | |
| SCHEMBL10816715 | 0.85 | CYP2D6 (0.45) | CYP1A2CYP3A4CYP2D6FGFR1 | |
| SCHEMBL10815175 | 0.85 | PDE3A (0.35) | CYP1A2TSHRCYP3A4CYP2D6FGFR1 | |
| SCHEMBL10814386 | 0.84 | P2RY1 (0.46) | CYP3A4CYP2D6FGFR1PDE3A | |
| SCHEMBL9583631 | 0.83 | CYP1A2 (0.48) | CYP1A2TSHRCYP3A4PDE3AALDH1A1 | |
| SCHEMBL10817453 | 0.82 | ADORA2A (0.51) | CYP3A4CYP2D6FGFR1ALDH1A1ADORA2A | |
| SCHEMBL10846484 | 0.82 | PDE3A (0.46) | CYP1A2TSHRCYP3A4CYP2D6FGFR1 | |
| SCHEMBL9583885 | 0.82 | CYP1A2 (0.50) | CYP1A2TSHRFGFR1PDE3AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0105135-B1 | SUBSTITUTED 9-(1-0- OR 3-0-MONOSUBSTITUTED OR 1,3-DI-0-SUBSTITUTED 1,3 DIHYDROXY-2-PROPOXYMETHYL) PURINES AS ANTIVIRAL AGENTS | SYNTEX (U.S.A.) INC. (US) | 1987-03-18 | — | — | EP | disclosed |
| US-4609661-A | HERPES VIRUS | SYNTEX (U.S.A.) INC. (US) | 1986-09-02 | — | — | US | disclosed |
| US-4556659-A | Substituted 9-(1-0- or 3-0-monosubstituted or 1,3-Di-0-substituted propoxymethyl)-purines as antiviral agents | SYNTEX (U.S.A.) INC. (US) | 1985-12-03 | — | — | US | disclosed |
| EP-0105135-A1 | Substituted 9-(1-0- or 3-0-monosubstituted or 1,3-di-0-substituted 1,3 dihydroxy-2-propoxymethyl) purines as antiviral agents | SYNTEX (U.S.A.) INC. (US) | 1984-04-11 | — | — | EP | disclosed |